Search

Your search keyword '"Rey, Pablo"' showing total 297 results

Search Constraints

Start Over You searched for: Author "Rey, Pablo" Remove constraint Author: "Rey, Pablo"
297 results on '"Rey, Pablo"'

Search Results

3. An approximate dynamic programming approach to network-based scheduling of chemotherapy treatment sessions.

6. Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

7. Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study

8. Should PRECISE-DAPT be included for long-term prognostic stratification of diabetic patients with NSTEACS?

11. Trasporte de productos químicos (HNS) en el ámbito marítimo: riesgos y amenazas

12. A column generation approach to intraday scheduling of chemotherapy patients.

22. Peapod FOS trial: A phase 2 clinical trial of pembrolizumab in combination with carboplatin and cabazitaxel in aggressive variant metastatic castration-resistant prostate cancer.

35. Abstract CT159: CYCLONE 1: abemaciclib in men with heavily pretreated metastatic castration-resistant prostate cancer (mCRPC)

36. Protocolo intensivo de estimulación eléctrica funcional y terapia en espejo tras un accidente cerebro vascular: estudio de caso

37. Obra de atraque para la descarga de granel líquido en el puerto exterior Punta Langosteira

38. Real-world treatment patterns, survival outcomes, and health care resource utilization (HCRU) for locally advanced or metastatic urothelial carcinoma (la/mUC) in Spain.

40. Dock to unload liquid bulks in the outer port Punta Langosteira

41. Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

43. Prognostic impact of renal function trajectories in patients with STEMI and kidney dysfunction undergoing primary percutaneous coronary intervention: An analysis of ten years all-comers registry

44. Safety and clinical activity of MEDI5752, a PD-1/CTLA-4 bispecific checkpoint inhibitor, as monotherapy in patients (pts) with advanced renal cell carcinoma (RCC): Preliminary results from an FTIH trial.

45. Impact of subsequent therapies in patients (pts) with advanced renal cell carcinoma (aRCC) receiving lenvatinib plus pembrolizumab (LEN + PEMBRO) or sunitinib (SUN) in the CLEAR study.

46. SEOM clinical guidelines for the treatment of advanced prostate cancer (2020)

47. Outcomes of men with HIV and germ cell cancer: Results from an international collaborative study

48. Outcomes of men with HIV and germ cell cancer:Results from an international collaborative study

49. Uso de la realidad virtual como medio de intervención en personas con daño cerebral adquirido

Catalog

Books, media, physical & digital resources